IMNN
Price
$5.75
Change
+$0.04 (+0.70%)
Updated
Sep 5 closing price
Capitalization
14.51M
72 days until earnings call
SPRO
Price
$2.15
Change
+$0.01 (+0.47%)
Updated
Sep 5 closing price
Capitalization
120.99M
72 days until earnings call
Interact to see
Advertisement

IMNN vs SPRO

Header iconIMNN vs SPRO Comparison
Open Charts IMNN vs SPROBanner chart's image
Imunon
Price$5.75
Change+$0.04 (+0.70%)
Volume$34.99K
Capitalization14.51M
Spero Therapeutics
Price$2.15
Change+$0.01 (+0.47%)
Volume$175.51K
Capitalization120.99M
IMNN vs SPRO Comparison Chart in %
Loading...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNN vs. SPRO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNN is a Hold and SPRO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (IMNN: $5.76 vs. SPRO: $2.15)
Brand notoriety: IMNN and SPRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNN: 14% vs. SPRO: 25%
Market capitalization -- IMNN: $14.51M vs. SPRO: $120.99M
IMNN [@Biotechnology] is valued at $14.51M. SPRO’s [@Biotechnology] market capitalization is $120.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNN’s FA Score shows that 0 FA rating(s) are green whileSPRO’s FA Score has 1 green FA rating(s).

  • IMNN’s FA Score: 0 green, 5 red.
  • SPRO’s FA Score: 1 green, 4 red.
According to our system of comparison, SPRO is a better buy in the long-term than IMNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNN’s TA Score shows that 3 TA indicator(s) are bullish while SPRO’s TA Score has 5 bullish TA indicator(s).

  • IMNN’s TA Score: 3 bullish, 4 bearish.
  • SPRO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SPRO is a better buy in the short-term than IMNN.

Price Growth

IMNN (@Biotechnology) experienced а -2.95% price change this week, while SPRO (@Biotechnology) price change was +3.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

IMNN is expected to report earnings on Nov 17, 2025.

SPRO is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRO($121M) has a higher market cap than IMNN($14.5M). SPRO YTD gains are higher at: 108.738 vs. IMNN (-53.556). IMNN has higher annual earnings (EBITDA): -14.79M vs. SPRO (-56.36M). SPRO has more cash in the bank: 31.2M vs. IMNN (4.73M). IMNN has less debt than SPRO: IMNN (1.19M) vs SPRO (3.62M). SPRO has higher revenues than IMNN: SPRO (34.1M) vs IMNN (0).
IMNNSPROIMNN / SPRO
Capitalization14.5M121M12%
EBITDA-14.79M-56.36M26%
Gain YTD-53.556108.738-49%
P/E RatioN/A10.75-
Revenue034.1M-
Total Cash4.73M31.2M15%
Total Debt1.19M3.62M33%
FUNDAMENTALS RATINGS
IMNN vs SPRO: Fundamental Ratings
IMNN
SPRO
OUTLOOK RATING
1..100
516
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9638
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SPRO's Valuation (50) in the Pharmaceuticals Major industry is in the same range as IMNN (57) in the Medical Specialties industry. This means that SPRO’s stock grew similarly to IMNN’s over the last 12 months.

SPRO's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that SPRO’s stock grew similarly to IMNN’s over the last 12 months.

SPRO's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that SPRO’s stock grew similarly to IMNN’s over the last 12 months.

SPRO's Price Growth Rating (38) in the Pharmaceuticals Major industry is somewhat better than the same rating for IMNN (96) in the Medical Specialties industry. This means that SPRO’s stock grew somewhat faster than IMNN’s over the last 12 months.

SPRO's P/E Growth Rating (7) in the Pharmaceuticals Major industry is significantly better than the same rating for IMNN (100) in the Medical Specialties industry. This means that SPRO’s stock grew significantly faster than IMNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMNNSPRO
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
66%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 17 days ago
74%
Bullish Trend 1 day ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CABA1.700.16
+10.39%
Cabaletta Bio
HSAI26.490.08
+0.30%
Hesai Group American Depositary Share each ADS represents one
AEE100.63-0.25
-0.25%
Ameren Corp
HRTG24.09-0.38
-1.55%
Heritage Insurance Holdings
EFOI2.44-0.07
-2.97%
Energy Focus

IMNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNN has been loosely correlated with REPL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNN jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
+0.61%
REPL - IMNN
61%
Loosely correlated
+8.95%
ABVX - IMNN
57%
Loosely correlated
+2.90%
SPRO - IMNN
41%
Loosely correlated
+0.47%
MRUS - IMNN
36%
Loosely correlated
+1.87%
CLSD - IMNN
30%
Poorly correlated
-1.23%
More

SPRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRO has been loosely correlated with ASBP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRO jumps, then ASBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRO
1D Price
Change %
SPRO100%
+0.47%
ASBP - SPRO
62%
Loosely correlated
-6.04%
CLGN - SPRO
42%
Loosely correlated
+4.31%
IMNN - SPRO
41%
Loosely correlated
+0.61%
ITOS - SPRO
35%
Loosely correlated
N/A
XENE - SPRO
32%
Poorly correlated
+1.48%
More